|
|
| Product Name: | HA-155 | | Synonyms: | Boronic acid, B-[4-[[4-[[3-[(4-fluorophenyl)methyl]-2,4-dioxo-5-thiazolidinylidene]methyl]phenoxy]methyl]phenyl]-;HA-155 4-((4-((3-(4-Fluorobenzyl)-2,4-dioxo-1,3-thiazolan-5-yliden)-methyl)phenoxy)methyl)benzene boronic acid;Autotaxin Inhibitor IV;inhibit,Inhibitor,HA155,Phosphodiesterase (PDE),(E/Z)-HA155,HA 155,Pain,Cancer,Inflammation,Angiogenesis,Fibrotic diseases,Autotaxin;(E/Z)-HA155 | | CAS: | 1229652-22-5 | | MF: | C24H19BFNO5S | | MW: | 463.29 | | EINECS: | | | Product Categories: | | | Mol File: | 1229652-22-5.mol |  |
| | HA-155 Chemical Properties |
| storage temp. | Store at -20°C | | solubility | DMF:50.0(Max Conc. mg/mL);107.92(Max Conc. mM)
DMSO:30.0(Max Conc. mg/mL);64.75(Max Conc. mM) | | form | A crystalline solid |
| | HA-155 Usage And Synthesis |
| Uses | HA 155 inhibits autotaxin (ATX) - mediated lysophosphatidylcholine (LPC) hydrolysis. |
| | HA-155 Preparation Products And Raw materials |
|